Philip Bath
Philip Bath
Stroke Association Professor of Stroke Medicine, University of Nottingham
Verified email at - Homepage
Cited by
Cited by
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008
European Stroke Organisation (ESO) Executive Committee, ...
Cerebrovascular diseases 25 (5), 457-507, 2008
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST …
IST-3 Collaborative Group
The Lancet 379 (9834), 2352-2363, 2012
Blood pressure and clinical outcomes in the International Stroke Trial
J Leonardi-Bee, PMW Bath, SJ Phillips, PAG Sandercock
Stroke 33 (5), 1315-1320, 2002
Platelet size: measurement, physiology and vascular disease
PMW Bath, RJ Butterworth
Blood coagulation & fibrinolysis 7 (2), 157-161, 1996
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
RL Sacco, HC Diener, S Yusuf, D Cotton, S Ōunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1238-1251, 2008
Telmisartan to prevent recurrent stroke and cardiovascular events
S Yusuf, HC Diener, RL Sacco, D Cotton, S Ōunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1225-1237, 2008
Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review
P Rashid, J Leonardi-Bee, P Bath
Stroke 34 (11), 2741-2748, 2003
High blood pressure in acute stroke and subsequent outcome: a systematic review
M Willmot, J Leonardi-Bee, PMW Bath
Hypertension 43 (1), 18-24, 2004
Influence of platelet size on outcome after myocardial infarction
JF Martin, PMW Bath, ML Burr
The Lancet 338 (8780), 1409-1411, 1991
Interventions for dysphagia and nutritional support in acute and subacute stroke
C Geeganage, J Beavan, S Ellender, PMW Bath
Cochrane Database of Systematic Reviews, 2012
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
EC Sandset, PMW Bath, G Boysen, D Jatuzis, J Kõrv, S Lüders, ...
The Lancet 377 (9767), 741-750, 2011
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy
ES Sena, HB Van Der Worp, PMW Bath, DW Howells, MR Macleod
PLoS biology 8 (3), e1000344, 2010
Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease
P Bath, C Algert, N Chapman, B Neal
Stroke 35 (3), 622-626, 2004
Vascular dysfunction—the disregarded partner of Alzheimer's disease
MD Sweeney, A Montagne, AP Sagare, DA Nation, LS Schneider, ...
Alzheimer's & Dementia 15 (1), 158-167, 2019
Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial
Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators
The Lancet 363 (9407), 439-445, 2004
Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro.
PM Bath, DG Hassall, AM Gladwin, RM Palmer, JF Martin
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 11 (2), 254-260, 1991
Post-stroke dysphagia: a review and design considerations for future trials
DL Cohen, C Roffe, J Beavan, B Blackett, CA Fairfield, S Hamdy, ...
International Journal of Stroke 11 (4), 399-411, 2016
Action plan for stroke in Europe 2018–2030
B Norrving, J Barrick, A Davalos, M Dichgans, C Cordonnier, A Guekht, ...
European stroke journal 3 (4), 309-336, 2018
Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke
CS Anderson, T Robinson, RI Lindley, H Arima, PM Lavados, TH Lee, ...
New England Journal of Medicine 374 (24), 2313-2323, 2016
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic …
HC Diener, RL Sacco, S Yusuf, D Cotton, S Ōunpuu, WA Lawton, ...
The Lancet Neurology 7 (10), 875-884, 2008
The system can't perform the operation now. Try again later.
Articles 1–20